Document is current
Any future updates will be listed below
-
Authors
Cheng, Miffy Hok Yan https://orcid.org/0000-0002-0261-4642
Zhang, Yao
Fox, Kevin
Leung, Jerry https://orcid.org/0000-0002-8714-8440
Strong, Colton https://orcid.org/0000-0003-4031-9932
Kang, Emma
Chen, Yihang
Tong, Michelle
Bommadevara, Hemashree
Jan, Eric https://orcid.org/0000-0003-0523-8467
Ip, Owen Yuk Long
Rodríguez-Rodríguez, Cristina https://orcid.org/0000-0002-3313-4422
Saatchi, Katayoun
Häfeli, Urs O. https://orcid.org/0000-0003-0671-4509
Abdolahzadeh, Amir
Witzigmann, Dominik
Cullis, Pieter R. https://orcid.org/0000-0001-9586-2508
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN 148469)
- License Information
-
More Information
Article History
Received: 24 June 2024
Accepted: 24 March 2025
First Online: 3 May 2025
Competing interests
: P.R.C. has a financial interest in Acuitas Therapeutics and NanoVation Therapeutics as well as being Chair of NanoVation Therapeutics. D.W. is an employee of NanoVation Therapeutics. M.H.Y.C hold equity in NanoVation Therapeutics. Inc. The remaining authors declare no competing interests.
